What to Watch When Johnson & Johnson Reports Tomorrow
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 95
Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy
Capricor Therapeutics shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy midstage trial.
Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients
Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application for ALKS 3831 to encompass the treatment of bipolar I disorder in addition…
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
Why Canaccord Genuity Is on the Sideline About Illumina
Illumina shares dropped on Friday after the firm announced a preliminary revenue miss and a 50% cut to its 2019 revenue growth guidance. As a result, a few analysts were quick to weigh in…
What’s So Great About Hookipa Pharma’s HPV Cancer Treatment
Hookipa Pharma is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update from the FDA.
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
Big Pharma Sees Rising Tide in Short Interest
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
How Microsoft Plans to Innovate the Hospital of the Future
Microsoft announced that it is working with Providence St. Joseph Health, a U.S. hospital chain, in an effort to build a new high-tech hospital.
What the Judge Did and Didn’t Say in the Drug Price Ruling
A federal District Court judge on Tuesday ruled that the U.S. Department of Health and Human Services could not force drug companies to include drug prices in their TV ads. But the saga may…
Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
Why Intra-Cellular Therapies’ Depression Study Is Nothing to Smile About
Intra-Cellular Therapies has announced top-line results from its two late-stage trial in patients with bipolar depression.
Tuesday’s Biggest Biotech Movers
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.